Articles with public access mandates - Masayuki NagahashiLearn more
Not available anywhere: 4
Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer
K Yuza, M Nagahashi, Y Shimada, M Nakano, Y Tajima, H Kameyama, ...
Journal of Surgical Research 231, 323-330, 2018
Mandates: US National Institutes of Health, Susan G. Komen
Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine‐1‐phosphate and ceramide in human hepatocellular carcinoma
K Miura, M Nagahashi, P Prasoon, Y Hirose, T Kobayashi, J Sakata, ...
Hepatology Research 51 (5), 614-626, 2021
Mandates: US National Institutes of Health
Clinical target sequencing for precision medicine of breast cancer
J Tsuchida, J Rothman, KA McDonald, M Nagahashi, K Takabe, T Wakai
International Journal of Clinical Oncology 24, 131-140, 2019
Mandates: US National Institutes of Health, Susan G. Komen
Targeting the Sphingosine-1-phosphate Signaling with FTY720 in Obesity Related Breast Cancer Progression
M Nagahashi, A Yamada, T Aoyagi, W Huang, JC Allegood, S Milstien, ...
Journal of Surgical Research 186 (2), 556, 2014
Mandates: US National Institutes of Health
Available somewhere: 72
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer
J Liang, M Nagahashi, EY Kim, KB Harikumar, A Yamada, WC Huang, ...
Cancer cell 23 (1), 107-120, 2013
Mandates: US National Institutes of Health
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis
M Nagahashi, S Ramachandran, EY Kim, JC Allegood, OM Rashid, ...
Cancer research 72 (3), 726-735, 2012
Mandates: US National Institutes of Health
Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes
E Studer, X Zhou, R Zhao, Y Wang, K Takabe, M Nagahashi, WM Pandak, ...
Hepatology 55 (1), 267-276, 2012
Mandates: US National Institutes of Health
Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2
K Takabe, RH Kim, JC Allegood, P Mitra, S Ramachandran, M Nagahashi, ...
Journal of Biological Chemistry 285 (14), 10477-10486, 2010
Mandates: US National Institutes of Health
The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice
Y Wang, H Aoki, J Yang, K Peng, R Liu, X Li, X Qiang, L Sun, EC Gurley, ...
Hepatology 65 (6), 2005-2018, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Targeting the SphK1/S1P/S1PR1 axis that links obesity, chronic inflammation, and breast cancer metastasis
M Nagahashi, A Yamada, E Katsuta, T Aoyagi, WC Huang, KP Terracina, ...
Cancer research 78 (7), 1713-1725, 2018
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression
M Nagahashi, K Takabe, R Liu, K Peng, X Wang, Y Wang, NC Hait, ...
Hepatology 61 (4), 1216-1226, 2015
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network
M Nagahashi, EY Kim, A Yamada, S Ramachandran, JC Allegood, ...
The FASEB Journal 27 (3), 1001, 2013
Mandates: US National Institutes of Health
Next generation sequencing‐based gene panel tests for the management of solid tumors
M Nagahashi, Y Shimada, H Ichikawa, H Kameyama, K Takabe, S Okuda, ...
Cancer science 110 (1), 6-15, 2019
Mandates: US National Institutes of Health, Susan G. Komen
Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer
K Moro, M Nagahashi, R Ramanathan, K Takabe, T Wakai
World journal of clinical cases 4 (7), 155, 2016
Mandates: US National Institutes of Health, Susan G. Komen
Is tail vein injection a relevant breast cancer lung metastasis model?
OM Rashid, M Nagahashi, S Ramachandran, CI Dumur, JC Schaum, ...
Journal of thoracic disease 5 (4), 385, 2013
Mandates: US National Institutes of Health
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
OM Rashid, M Nagahashi, S Ramachandran, L Graham, A Yamada, ...
Surgery 153 (6), 771-778, 2013
Mandates: US National Institutes of Health
Sphingosine‐1‐phosphate transporters as targets for cancer therapy
M Nagahashi, K Takabe, KP Terracina, D Soma, Y Hirose, T Kobayashi, ...
BioMed research international 2014 (1), 651727, 2014
Mandates: US National Institutes of Health
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
NC Hait, D Avni, A Yamada, M Nagahashi, T Aoyagi, H Aoki, CI Dumur, ...
Oncogenesis 4 (6), e156-e156, 2015
Mandates: US National Institutes of Health
The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+/HER2− breast cancer
M Oshi, H Takahashi, Y Tokumaru, L Yan, OM Rashid, M Nagahashi, ...
Cells 9 (7), 1643, 2020
Mandates: US National Institutes of Health, Susan G. Komen
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
M Nagahashi, K Yuza, Y Hirose, M Nakajima, R Ramanathan, NC Hait, ...
Journal of lipid research 57 (9), 1636-1643, 2016
Mandates: US National Institutes of Health, Susan G. Komen
Publication and funding information is determined automatically by a computer program